BridgeMD
New treatment option for Arthroplasty, Replacement, Shoulder
Official title At Home, Digital Rehabilitation for Patients After Reverse Total Shoulder Arthroplasty
ClinicalTrials.gov ID: NCT06891378
What this study is testing
- What it's testing
- 1. Why This Study Matters Over the past five years, more people in Korea have been having shoulder surgery.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 and older
You may be able to join if
- Those aged 50 or older
- Those who are indicated for and are scheduled to undergo reverse total shoulder arthroplasty (RTSA)
- Those who voluntarily decided to participate and gave written consent after hearing a detailed explanation of this study
You likely can't join if
- Those who have difficulty using the application due to severe underlying diseases, neuromusculoskeletal diseases, cognitive or visual impairments...
- Those with concomitant diseases such as neurological or visual impairments or uncontrolled cardiovascular disorders that make it difficult to...
- Other people who, as determined by a medical professional, should not perform rehabilitation exercises without supervision
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, Irwon-ro 81, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, Irwon-ro 81, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.